{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:42:57Z","timestamp":1787319777611,"version":"build-2736575974"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.gene.2026.150244","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:55:21Z","timestamp":1780070121000},"page":"150244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["c-Myc as a vulnerable target in cancer drug resistance"],"prefix":"10.1016","volume":"1007","author":[{"given":"Milad","family":"Ashrafizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2026.150244_b0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1476-4598-13-54","article-title":"Regulation of CDKN2B expression by interaction of Arnt with Miz-1 - a basis for functional integration between the HIF and Myc gene regulatory pathways","volume":"13","author":"Aesoy","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2026.150244_b0010","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12967-023-03969-z","article-title":"BAX as the mediator of C-MYC sensitizes acute lymphoblastic leukemia to TLR9 agonists","volume":"21","author":"Bai","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.gene.2026.150244_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216178","article-title":"m(6)A-modification of cyclin D1 and c-myc IRESs in glioblastoma controls ITAF activity and resistance to mTOR inhibition","volume":"562","author":"Benavides-Serrato","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.gene.2026.150244_b0020","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1093\/nar\/gkz344","article-title":"c-MYC empowers transcription and productive splicing of the oncogenic splicing factor Sam68 in cancer","volume":"47","author":"Caggiano","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2026.150244_b0025","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41419-021-03685-w","article-title":"Directly targeting c-Myc contributes to the anti-multiple myeloma effect of anlotinib","volume":"12","author":"Cao","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150244_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14225538","article-title":"UCHL5 promotes proliferation and migration of bladder cancer cells by activating c-Myc via AKT\/mTOR signaling","volume":"14","author":"Cao","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.gene.2026.150244_b0035","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.1038\/s41598-018-28107-4","article-title":"A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferation","volume":"8","author":"Castell","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2026.150244_b0040","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1158\/2767-9764.CRC-21-0019","article-title":"MYCMI-7: a small MYC-binding compound that inhibits MYC: MAX interaction and tumor growth in a MYC-dependent manner","volume":"2","author":"Castell","year":"2022","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.gene.2026.150244_b0045","article-title":"Meclofenamic acid restores gefinitib sensitivity by downregulating breast cancer resistance protein and multidrug resistance protein 7 via FTO\/m6A-demethylation\/c-Myc in non-small cell lung cancer","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.gene.2026.150244_b0050","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.gene.2026.150244_b0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00432-025-06124-x","article-title":"Bufalin targets the SRC-3\/c-Myc pathway in chemoresistant cells to regulate metastasis induced by chemoresistance in colorectal cancer","volume":"151","author":"Chen","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.gene.2026.150244_b0060","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00432-018-2696-3","article-title":"Disruption of MEK\/ERK\/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo","volume":"144","author":"Ciccarelli","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.gene.2026.150244_b0065","first-page":"156","article-title":"Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression","volume":"56","author":"Daga","year":"2019","journal-title":"Phytomed. Int. J. Phytother. Phytopharmacol."},{"key":"10.1016\/j.gene.2026.150244_b0070","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/s41556-024-01360-8","article-title":"A guideline on the molecular ecosystem regulating ferroptosis","volume":"26","author":"Dai","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.gene.2026.150244_b0075","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2006.07.014","article-title":"The c-Myc target gene network","volume":"16","author":"Dang","year":"2006","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.gene.2026.150244_b0080","article-title":"The c-MYC-WDR43 signalling axis promotes chemoresistance and tumour growth in colorectal cancer by inhibiting p53 activity","volume":"66","author":"Di","year":"2023","journal-title":"Drug Resist. Updates Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.gene.2026.150244_b0085","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.gene.2026.150244_b0090","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1038\/s41467-020-18735-8","article-title":"c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis","volume":"11","author":"Feng","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2026.150244_b0095","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.gastro.2021.09.017","article-title":"Mucin 5AC serves as the nexus for \u03b2-catenin\/c-Myc interplay to promote glutamine dependency during pancreatic cancer chemoresistance","volume":"162","author":"Ganguly","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gene.2026.150244_b0100","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/s41467-025-56894-8","article-title":"Targeting ELOVL6 to disrupt c-MYC driven lipid metabolism in pancreatic cancer enhances chemosensitivity","volume":"16","author":"Garc\u00eda Garc\u00eda","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2026.150244_b0105","first-page":"3654","article-title":"Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-Type peptide fused to an internalization sequence1","volume":"58","author":"Giorello","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150244_b0110","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/s41417-023-00624-z","article-title":"FIT links c-Myc and P53 acetylation by recruiting RBBP7 during colorectal carcinogenesis","volume":"30","author":"Guo","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.gene.2026.150244_b0115","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/s41419-018-0887-0","article-title":"PAK2-c-Myc-PKM2 axis plays an essential role in head and neck oncogenesis via regulating Warburg effect","volume":"9","author":"Gupta","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150244_b0120","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1038\/onc.2008.312","article-title":"Apoptotic signaling by c-MYC","volume":"27","author":"Hoffman","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2026.150244_b0125","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/1878-0261.12395","article-title":"Transcriptional upregulation of c-MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma","volume":"12","author":"Hong","year":"2018","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.gene.2026.150244_b0130","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41420-023-01682-w","article-title":"Nucleophosmin 1 cooperates with BRD4 to facilitate c-Myc transcription to promote prostate cancer progression","volume":"9","author":"Hong","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.gene.2026.150244_b0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41420-022-00815-x","article-title":"ZC3H15 promotes gastric cancer progression by targeting the FBXW7\/c-Myc pathway","volume":"8","author":"Hou","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.gene.2026.150244_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.824043","article-title":"Z-Ligustilide induces c-Myc-dependent apoptosis via activation of ER-stress signaling in hypoxic oral cancer cells","volume":"12","author":"Hsu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.gene.2026.150244_b0145","doi-asserted-by":"crossref","unstructured":"Hu, D., Li, M., Chen, X., 2024. DLX5 promotes radioresistance in renal cell carcinoma by upregulating c-Myc expression. Front. Biosci. (Landmark Edition) 2024, 29, 400. Doi: 10.31083\/j.fbl2911400.","DOI":"10.31083\/j.fbl2911400"},{"key":"10.1016\/j.gene.2026.150244_b0150","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/stem.2668","article-title":"Colorectal cancer stem cells acquire chemoresistance through the upregulation of F-Box\/WD repeat-containing protein 7 and the consequent degradation of c-Myc","volume":"35","author":"Izumi","year":"2017","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"10.1016\/j.gene.2026.150244_b0155","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1038\/s41598-017-03763-0","article-title":"TCRP1 transcriptionally regulated by c-Myc confers cancer chemoresistance in tongue and lung cancer","volume":"7","author":"Jia","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2026.150244_b0160","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1124\/mol.109.054858","article-title":"Stabilizers of the max homodimer identified in virtual ligand screening inhibit Myc function","volume":"76","author":"Jiang","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.gene.2026.150244_b0165","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.7150\/thno.19988","article-title":"EGLN1\/c-myc induced lymphoid-specific helicase inhibits ferroptosis through lipid metabolic gene expression changes","volume":"7","author":"Jiang","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.gene.2026.150244_b0170","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.gene.2026.150244_b0175","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1158\/0008-5472.CAN-21-2988","article-title":"EIF4A3-induced circARHGAP29 promotes aerobic glycolysis in docetaxel-resistant prostate cancer through IGF2BP2\/c-Myc\/LDHA signaling","volume":"82","author":"Jiang","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150244_b0180","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12943-024-02052-5","article-title":"Circular RNA hsa_circ_0000467 promotes colorectal cancer progression by promoting eIF4A3-mediated c-Myc translation","volume":"23","author":"Jiang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2026.150244_b0185","first-page":"463","article-title":"PES1 promotes BET inhibitors resistance and cells proliferation through increasing c-Myc expression in pancreatic cancer","volume":"38","author":"Jin","year":"2019","journal-title":"J. Exp. Clinical Cancer Res. CR"},{"key":"10.1016\/j.gene.2026.150244_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/cells11244127","article-title":"C-MYC Inhibited Ferroptosis and Promoted Immune Evasion in Ovarian Cancer Cells through NCOA4 Mediated Ferritin Autophagy","volume":"11","author":"Jin","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.gene.2026.150244_b0195","first-page":"198","article-title":"NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer","volume":"41","author":"Jing","year":"2022","journal-title":"J. Exp. Clinical Cancer Res. CR"},{"key":"10.1016\/j.gene.2026.150244_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151495","article-title":"TPD52 (isoform 3) promotes resistance to mTOR-targeted inhibitors by regulating c-Myc, PTEN, and direct activation of 4E-BP1 in LNCaP androgen-dependent cells","volume":"753","author":"Khilar","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.gene.2026.150244_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113198","article-title":"Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4\/6 inhibitors in breast cancer","volume":"42","author":"Kim","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.gene.2026.150244_b0210","first-page":"796","article-title":"Suppression of multidrug resistance by treatment with TRAIL in human ovarian and breast cancer cells with high level of c-Myc","volume":"1812","author":"Kim","year":"2011","journal-title":"BBA"},{"key":"10.1016\/j.gene.2026.150244_b0215","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00001813-200301000-00006","article-title":"Resistance to chemotherapeutic drugs overcome by c-Myc inhibition in a Lewis lung carcinoma murine model","volume":"14","author":"Knapp","year":"2003","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.gene.2026.150244_b0220","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1158\/1541-7786.MCR-13-0377","article-title":"PGE2-driven expression of c-Myc and oncomiR-17-92 contributes to apoptosis resistance in NSCLC","volume":"12","author":"Krysan","year":"2014","journal-title":"Mol. Cancer Res. MCR"},{"key":"10.1016\/j.gene.2026.150244_b0225","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/jcmm.12531","article-title":"The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracil resistance in human colon cancer cells","volume":"19","author":"Kugimiya","year":"2015","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.gene.2026.150244_b0230","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.7150\/thno.42602","article-title":"Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation","volume":"10","author":"Le Grand","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.gene.2026.150244_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109631","article-title":"HMGB1 release promotes paclitaxel resistance in castration-resistant prostate cancer cells via activating c-Myc expression","volume":"72","author":"Lei","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.gene.2026.150244_b0240","doi-asserted-by":"crossref","unstructured":"Li, F., Yu, J., Pan, T., Feng, H., Li, J., Yu, B., Fan, Z., Sang, Q., Chen, M., Zang, M., et al., 2023. BPTF drives gastric cancer resistance to EGFR inhibitor by epigenetically regulating the C-MYC\/PLCG1\/Perk axis. Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany) 2023, 10, e2303091. Doi: 10.1002\/advs.202303091.","DOI":"10.1002\/advs.202303091"},{"key":"10.1016\/j.gene.2026.150244_b0245","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.clbc.2022.11.006","article-title":"USP22 contributes to chemoresistance, stemness, and EMT phenotype of triple-negative breast cancer cells by egulating the Warburg effect via c-Myc deubiquitination","volume":"23","author":"Li","year":"2023","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.gene.2026.150244_b0250","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.7150\/thno.34887","article-title":"C-myc\/miR-150\/EPG5 axis mediated dysfunction of autophagy promotes development of non-small cell lung cancer","volume":"9","author":"Li","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.gene.2026.150244_b0255","first-page":"313","article-title":"circ-hnRNPU inhibits NONO-mediated c-Myc transactivation and mRNA stabilization essential for glycosylation and cancer progression","volume":"42","author":"Li","year":"2023","journal-title":"J. Exp. Clinical Cancer Res. CR"},{"key":"10.1016\/j.gene.2026.150244_b0260","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stem.2014.08.001","article-title":"SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells","volume":"15","author":"Li","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.gene.2026.150244_b0265","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1038\/s41388-021-01957-5","article-title":"FBP1 regulates proliferation, metastasis, and chemoresistance by participating in C-MYC\/STAT3 signaling axis in ovarian cancer","volume":"40","author":"Li","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2026.150244_b0270","first-page":"49","article-title":"The role of c-Myc-RBM38 loop in the growth suppression in breast cancer","volume":"36","author":"Li","year":"2017","journal-title":"J. Experim. Clinical Cancer Res. CR"},{"key":"10.1016\/j.gene.2026.150244_b0275","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1111\/jcmm.15322","article-title":"Molecular mechanism of c-Myc and PRPS1\/2 against thiopurine resistance in Burkitt's lymphoma","volume":"24","author":"Li","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.gene.2026.150244_b0280","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3233\/CBM-170452","article-title":"miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal","volume":"21","author":"Li","year":"2017","journal-title":"Cancer Biomark. Sec. A Disease Mark."},{"key":"10.1016\/j.gene.2026.150244_b0285","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41419-024-06446-7","article-title":"USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150244_b0290","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10565-021-09650-9","article-title":"Long non-coding RNA CTSLP8 mediates ovarian cancer progression and chemotherapy resistance by modulating cellular glycolysis and regulating c-Myc expression through PKM2","volume":"38","author":"Li","year":"2022","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.gene.2026.150244_b0295","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1186\/s12885-021-08855-9","article-title":"Tryptophan metabolism induced by TDO2 promotes prostatic cancer chemotherapy resistance in a AhR\/c-Myc dependent manner","volume":"21","author":"Li","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gene.2026.150244_b0300","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41419-024-06469-0","article-title":"FSTL3 promotes tumor immune evasion and attenuates response to anti-PD1 therapy by stabilizing c-Myc in colorectal cancer","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150244_b0305","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41419-019-1457-9","article-title":"VPS33B interacts with NESG1 to modulate EGFR\/PI3K\/AKT\/c-Myc\/P53\/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma","volume":"10","author":"Liang","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150244_b0310","doi-asserted-by":"crossref","first-page":"65642","DOI":"10.18632\/oncotarget.20020","article-title":"VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.gene.2026.150244_b0315","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/gt.2015.39","article-title":"Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc","volume":"22","author":"Liu","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.gene.2026.150244_b0320","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.canlet.2018.11.030","article-title":"Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating \u03b2-catenin\/c-Myc signaling in human hepatocellular carcinoma","volume":"443","author":"Liu","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.gene.2026.150244_b0325","doi-asserted-by":"crossref","first-page":"e944","DOI":"10.1002\/ctm2.944","article-title":"Lipid metabolism-related lncRNA SLC25A21-AS1 promotes the progression of oesophageal squamous cell carcinoma by regulating the NPM1\/c-Myc axis and SLC25A21 expression","volume":"12","author":"Liu","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.gene.2026.150244_b0330","article-title":"Tumor suppressor DYRK1A effects on proliferation and chemoresistance of AML cells by downregulating c-Myc","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2026.150244_b0335","article-title":"Nuclear hexokinase 2 couples hyperglycemia to MYC-driven glycolytic and stemness programs in bladder cancer","author":"Liu","year":"2026","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150244_b0340","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s11010-022-04416-1","article-title":"Methionine restriction enhances the chemotherapeutic sensitivity of colorectal cancer stem cells by miR-320d\/c-Myc axis","volume":"477","author":"Liu","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.gene.2026.150244_b0345","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41419-023-06226-9","article-title":"Salicylate induces AMPK and inhibits c-MYC to activate a NRF2\/ARE\/miR-34a\/b\/c cascade resulting in suppression of colorectal cancer metastasis","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150244_b0350","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41419-024-07045-2","article-title":"NEK6 dampens FOXO3 nuclear translocation to stabilize C-MYC and promotes subsequent de novo purine synthesis to support ovarian cancer chemoresistance","volume":"15","author":"Liu","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150244_b0355","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1158\/0008-5472.CAN-22-1247","article-title":"SMAD4 loss induces c-MYC-mediated NLE1 upregulation to support protein biosynthesis, colorectal cancer growth, and metastasis","volume":"82","author":"Loevenich","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150244_b0360","doi-asserted-by":"crossref","first-page":"10607","DOI":"10.1038\/s41598-017-10886-x","article-title":"Hyper-O-GlcNAcylation induces cisplatin resistance via regulation of p53 and c-Myc in human lung carcinoma","volume":"7","author":"Luanpitpong","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2026.150244_b0365","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1093\/brain\/awv287","article-title":"c-Myc-miR-29c-REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma","volume":"138","author":"Luo","year":"2015","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.gene.2026.150244_b0370","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/s41418-019-0475-6","article-title":"ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb\/E2F1\/c-Myc-mediated cancer stemness","volume":"27","author":"Luo","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.gene.2026.150244_b0375","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12967-017-1357-7","article-title":"Disruption of the c-Myc\/miR-200b-3p\/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer","volume":"15","author":"Lv","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.gene.2026.150244_b0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15384047.2022.2125748","article-title":"BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes","volume":"23","author":"Ma","year":"2022","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.gene.2026.150244_b0385","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41392-024-01772-w","article-title":"Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer","volume":"9","author":"Ma","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.gene.2026.150244_b0390","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12943-020-01291-6","article-title":"Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc","volume":"20","author":"Madden","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2026.150244_b0395","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41419-023-06248-3","article-title":"c-MYC-dependent transcriptional inhibition of autophagy is implicated in cisplatin sensitivity in HPV-positive head and neck cancer","volume":"14","author":"Medda","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150244_b0400","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1158\/1078-0432.CCR-12-0977","article-title":"c-Myc and Cancer Metabolism","volume":"18","author":"Miller","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.gene.2026.150244_b0405","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12943-022-01642-5","article-title":"S6K1 amplification confers innate resistance to CDK4\/6 inhibitors through activating c-Myc pathway in patients with estrogen receptor-positive breast cancer","volume":"21","author":"Mo","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2026.150244_b0410","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/s41388-024-03048-7","article-title":"CRL2(KLHDC3) and CRL1(Fbxw7) cooperatively mediate c-Myc degradation","volume":"43","author":"Motomura","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2026.150244_b0415","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/15384047.2017.1345384","article-title":"Macrocyclic peptides decrease c-Myc protein levels and reduce prostate cancer cell growth","volume":"18","author":"Mukhopadhyay","year":"2017","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.gene.2026.150244_b0420","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/s41416-022-02118-5","article-title":"PTBP1 drives c-Myc-dependent gastric cancer progression and stemness","volume":"128","author":"Ni","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.gene.2026.150244_b0425","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.7150\/ijbs.77150","article-title":"PI3K\/ c-Myc\/AFF4 axis promotes pancreatic tumorigenesis through fueling nucleotide metabolism","volume":"19","author":"Ni","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.gene.2026.150244_b0430","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.7150\/thno.20861","article-title":"Brusatol-mediated inhibition of c-Myc increases HIF-1\u03b1 degradation and causes cell death in colorectal cancer under hypoxia","volume":"7","author":"Oh","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.gene.2026.150244_b0435","article-title":"Inhibition of c-Myc overcomes cytotoxic drug resistance in acute myeloid leukemia cells by promoting differentiation","volume":"9","author":"Pan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2026.150244_b0440","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1038\/onc.2014.327","article-title":"USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer","volume":"34","author":"Pan","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2026.150244_b0445","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/gutjnl-2015-310255","article-title":"BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis","volume":"66","author":"Parang","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.gene.2026.150244_b0450","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1158\/1541-7786.MCR-19-0191","article-title":"The sustained induction of c-MYC drives Nab-paclitaxel resistance in primary pancreatic ductal carcinoma cells","volume":"17","author":"Parasido","year":"2019","journal-title":"Mol. Cancer Res. MCR"},{"key":"10.1016\/j.gene.2026.150244_b0455","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417589","article-title":"Acetylcorynoline induces apoptosis and G2\/M phase arrest through the c-Myc signaling pathway in colon cancer cells","volume":"24","author":"Park","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2026.150244_b0460","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-024-02031-w","article-title":"Polyamine and EIF5A hypusination downstream of c-Myc confers targeted therapy resistance in BRAF mutant melanoma","volume":"23","author":"Park","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2026.150244_b0465","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0003-9861(03)00294-7","article-title":"The many faces of c-MYC","volume":"416","author":"Pelengaris","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.gene.2026.150244_b0470","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2403331121","article-title":"USP11 promotes prostate cancer progression by up-regulating AR and c-Myc activity","volume":"121","author":"Pornour","year":"2024","journal-title":"PNAS"},{"key":"10.1016\/j.gene.2026.150244_b0475","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1038\/sj.onc.1202727","article-title":"Mechanisms of apoptosis by c-Myc","volume":"18","author":"Prendergast","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2026.150244_b0480","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1158\/1078-0432.CCR-19-0206","article-title":"Arginine starvation and docetaxel induce c-Myc-driven hENT1 surface expression to overcome gemcitabine resistance in ASS1-negative tumors","volume":"25","author":"Prudner","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.gene.2026.150244_b0485","doi-asserted-by":"crossref","first-page":"ra19","DOI":"10.1126\/scisignal.2001556","article-title":"c-MYC suppresses BIN1 to release poly(ADP-ribose) polymerase 1: a mechanism by which cancer cells acquire cisplatin resistance","volume":"4","author":"Pyndiah","year":"2011","journal-title":"Sci. Signal."},{"key":"10.1016\/j.gene.2026.150244_b0490","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11010-017-3177-8","article-title":"Knockdown of long non-coding RNA prostate cancer-associated ncRNA transcript 1 inhibits multidrug resistance and c-Myc-dependent aggressiveness in colorectal cancer Caco-2 and HT-29 cells","volume":"441","author":"Qiao","year":"2018","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.gene.2026.150244_b0495","doi-asserted-by":"crossref","first-page":"10153","DOI":"10.1038\/ncomms10153","article-title":"BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis","volume":"7","author":"Richart","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2026.150244_b0500","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/07357907.2019.1651328","article-title":"Synergistic effects of PI3K and c-Myc Co-targeting in acute leukemia: shedding new light on resistance to selective PI3K-\u03b4 inhibitor CAL-101","volume":"37","author":"Riyahi","year":"2019","journal-title":"Cancer Invest."},{"key":"10.1016\/j.gene.2026.150244_b0505","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood.2019002922","article-title":"Mechanistic basis and efficacy of targeting the \u03b2-catenin-TCF7L2-JMJD6-c-Myc axis to overcome resistance to BET inhibitors","volume":"135","author":"Saenz","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.gene.2026.150244_b0510","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1124\/mol.107.043372","article-title":"Inhibition of c-Myc down-regulation by sustained extracellular signal-regulated kinase activation prevents the antimetabolite methotrexate- and gemcitabine-induced differentiation in non-small-cell lung cancer cells","volume":"73","author":"Serra","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.gene.2026.150244_b0515","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4149\/neo_2021_210518N681","article-title":"Girdin influences pancreatic cancer progression by regulating c-MYC expression","volume":"69","author":"Shan","year":"2022","journal-title":"Neoplasma"},{"key":"10.1016\/j.gene.2026.150244_b0520","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12967-023-03985-z","article-title":"P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization","volume":"21","author":"Sheng","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.gene.2026.150244_b0525","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/cdd.2017.176","article-title":"A miR-20a\/MAPK1\/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance","volume":"25","author":"Si","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.gene.2026.150244_b0530","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.chembiol.2019.02.009","article-title":"Stabilization of the max homodimer with a small molecule attenuates Myc-driven transcription","volume":"26","author":"Struntz","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.gene.2026.150244_b0535","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.apsb.2021.09.014","article-title":"c-MYC-mediated TRIB3\/P62(+) aggresomes accumulation triggers paraptosis upon the combination of everolimus and ginsenoside Rh2","volume":"12","author":"Su","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.gene.2026.150244_b0540","doi-asserted-by":"crossref","unstructured":"Sun, Y., Yu, M., Qu, M., Ma, Y., Zheng, D., Yue, Y., Guo, S., Tang, L., Li, G., Zheng, W., et al., 2020. Hepatitis B virus-triggered PTEN\/\u03b2-catenin\/c-Myc signaling enhances PD-L1 expression to promote immune evasion. American journal of physiology. Gastrointestinal and liver physiology, 2020, 318, G162-g173. Doi: 10.1152\/ajpgi.00197.2019.","DOI":"10.1152\/ajpgi.00197.2019"},{"key":"10.1016\/j.gene.2026.150244_b0545","first-page":"148","article-title":"The aberrant expression of ADAR1 promotes resistance to BET inhibitors in pancreatic cancer by stabilizing c-Myc","volume":"10","author":"Sun","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.gene.2026.150244_b0550","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000405","article-title":"Oxyberberine sensitizes liver cancer cells to sorafenib via inhibiting NOTCH1-USP7-c-Myc pathway","volume":"8","author":"Sun","year":"2024","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.gene.2026.150244_b0555","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.7150\/thno.37621","article-title":"The c-Myc\/miR-27b-3p\/ATG10 regulatory axis regulates chemoresistance in colorectal cancer","volume":"10","author":"Sun","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.gene.2026.150244_b0560","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41419-024-07254-9","article-title":"Oncogenic RTKs sensitize cancer cells to ferroptosis via c-Myc mediated upregulation of ACSL4","volume":"15","author":"Sun","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150244_b0565","article-title":"Targeting SMYD2 promotes ferroptosis and impacts the progression of pancreatic cancer through the c-Myc\/NCOA4 axis-mediated ferritinophagy","volume":"1868","author":"Tan","year":"2024","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.gene.2026.150244_b0570","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.7150\/thno.53417","article-title":"c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation","volume":"11","author":"Tang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.gene.2026.150244_b0575","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1038\/s41467-019-11447-8","article-title":"LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc","volume":"10","author":"Tang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2026.150244_b0580","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1158\/0008-5472.CAN-11-3605","article-title":"Activation of Ras\/PI3K\/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells","volume":"72","author":"Tsai","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150244_b0585","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbrc.2022.03.138","article-title":"c-MYC-USP49-BAG2 axis promotes proliferation and chemoresistance of colorectal cancer cells invitro","volume":"607","author":"Tu","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.gene.2026.150244_b0590","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.omtn.2021.07.003","article-title":"hsa_circ_0068631 promotes breast cancer progression through c-Myc by binding to EIF4A3","volume":"26","author":"Wang","year":"2021","journal-title":"Mol. Therapy Nucleic Acids"},{"key":"10.1016\/j.gene.2026.150244_b0595","doi-asserted-by":"crossref","unstructured":"Wang, Z., Li, Y., Yang, J., Sun, Y., He, Y., Wang, Y., Liang, Y., Chen, X., Chen, T., Han, D., et al., 2024. CircCFL1 promotes TNBC stemness and Immunoescape via deacetylation-mediated c-Myc deubiquitylation to facilitate mutant TP53 transcription. Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany), 2024, 11, e2404628. Doi: 10.1002\/advs.202404628.","DOI":"10.1002\/advs.202404628"},{"key":"10.1016\/j.gene.2026.150244_b0600","doi-asserted-by":"crossref","unstructured":"Wang, X., Wang, X., Gu, J., Wei, Y., Wang, Y., 2025. circUBR5 promotes ribosome biogenesis and induces docetaxel resistance in triple-negative breast cancer cell lines via the miR-340-5p\/CMTM6\/c-MYC axis. Neoplasia (New York, N.Y.) 2025, 59, pp. 101062. Doi: 10.1016\/j.neo.2024.101062.","DOI":"10.1016\/j.neo.2024.101062"},{"key":"10.1016\/j.gene.2026.150244_b0605","article-title":"Aspalathus linearis suppresses cell survival and proliferation of enzalutamide-resistant prostate cancer cells via inhibition of c-Myc and stability of androgen receptor","volume":"17","author":"Wang","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2026.150244_b0610","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169365","article-title":"USP47 inhibits m6A-dependent c-Myc translation to maintain regulatory T cell metabolic and functional homeostasis","volume":"133","author":"Wang","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.gene.2026.150244_b0615","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/s41401-021-00750-0","article-title":"Helichrysetin inhibits gastric cancer growth by targeting c-Myc\/PDHK1 axis-mediated energy metabolism reprogramming","volume":"43","author":"Wang","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.gene.2026.150244_b0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.139777","article-title":"The MCM6-c-Myc positive feedback loop mediates bladder cancer progression and cisplatin resistance","volume":"296","author":"Wang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.gene.2026.150244_b0625","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/onc.2015.106","article-title":"SCP1 regulates c-Myc stability and functions through dephosphorylating c-Myc Ser62","volume":"35","author":"Wang","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2026.150244_b0630","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41420-021-00696-6","article-title":"RCN1 induces sorafenib resistance and malignancy in hepatocellular carcinoma by activating c-MYC signaling via the IRE1\u03b1-XBP1s pathway","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.gene.2026.150244_b0635","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1038\/s41388-023-02744-0","article-title":"The DUBA-SLC7A11-c-Myc axis is critical for stemness and ferroptosis","volume":"42","author":"Wang","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2026.150244_b0640","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.7150\/jca.95549","article-title":"ACAT1 promotes proliferation and metastasis of bladder cancer via AKT\/GSK3\u03b2\/c-Myc signaling pathway","volume":"15","author":"Wang","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.gene.2026.150244_b0645","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12943-022-01622-9","article-title":"E3 ubiquitin ligase MAGI3 degrades c-Myc and acts as a predictor for chemotherapy response in colorectal cancer","volume":"21","author":"Wang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2026.150244_b0650","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41418-024-01315-4","article-title":"The OGT-c-Myc-PDK2 axis rewires the TCA cycle and promotes colorectal tumor growth","volume":"31","author":"Wang","year":"2024","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.gene.2026.150244_b0655","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s42255-024-01037-4","article-title":"Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc","volume":"6","author":"Wang","year":"2024","journal-title":"Nature Metabolism"},{"key":"10.1016\/j.gene.2026.150244_b0660","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1530\/ERC-18-0193","article-title":"KAT5 promotes invasion and metastasis through C-MYC stabilization in ATC","volume":"26","author":"Wei","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"issue":"1152\u20131168","key":"10.1016\/j.gene.2026.150244_b0665","article-title":"c-MYC and HIF1\u03b1 promoter G-quadruplexes dependent metabolic regulation mechanism of berberine in colon cancer","volume":"13","author":"Wen","year":"2022","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.gene.2026.150244_b0670","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.7150\/thno.58729","article-title":"Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer","volume":"11","author":"Wu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.gene.2026.150244_b0675","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1038\/s41418-023-01225-x","article-title":"LncRNA BCAN-AS1 stabilizes c-Myc via N(6)-methyladenosine-mediated binding with SNIP1 to promote pancreatic cancer","volume":"30","author":"Wu","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.gene.2026.150244_b0680","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.leukres.2014.11.004","article-title":"c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia","volume":"39","author":"Xia","year":"2015","journal-title":"Leuk. Res."},{"key":"10.1016\/j.gene.2026.150244_b0685","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/abbs\/gmy076","article-title":"PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression","volume":"50","author":"Xiang","year":"2018","journal-title":"Acta Biochim. Biophy. Sin."},{"key":"10.1016\/j.gene.2026.150244_b0690","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1269\/jrr.11062","article-title":"SirT1 confers hypoxia-induced radioresistance via the modulation of c-Myc stabilization on hepatoma cells","volume":"53","author":"Xie","year":"2012","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.gene.2026.150244_b0695","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/s41388-024-02991-9","article-title":"tiRNA-Val-CAC-2 interacts with FUBP1 to promote pancreatic cancer metastasis by activating c\u2011MYC transcription","volume":"43","author":"Xiong","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2026.150244_b0700","doi-asserted-by":"crossref","unstructured":"Xu, Y., Yu, Q., Wang, P., Wu, Z., Zhang, L., Wu, S., Li, M., Wu, B., Li, H., Zhuang, H., et al., 2022. A Selective Small-Molecule c-Myc Degrader Potently Regresses Lethal c-Myc Overexpressing Tumors. Adv. Sci., (Weinheim, Baden-Wurttemberg, Germany) 2022, 9, e2104344. Doi: 10.1002\/advs.202104344.","DOI":"10.1002\/advs.202104344"},{"key":"10.1016\/j.gene.2026.150244_b0705","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2406936121","article-title":"TRIM21 induces selective autophagic degradation of c-Myc and sensitizes regorafenib therapy in colorectal cancer","volume":"121","author":"Ye","year":"2024","journal-title":"PNAS"},{"key":"10.1016\/j.gene.2026.150244_b0710","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1038\/sj.onc.1206641","article-title":"Low molecular weight inhibitors of Myc\u2013Max interaction and function","volume":"22","author":"Yin","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2026.150244_b0715","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.freeradbiomed.2023.09.006","article-title":"Canagliflozin reduces chemoresistance in hepatocellular carcinoma through PKM2-c-Myc complex-mediated glutamine starvation","volume":"208","author":"Zeng","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.gene.2026.150244_b0720","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12943-015-0326-0","article-title":"Sp1 and c-Myc modulate drug resistance of leukemia stem cells by regulating survivin expression through the ERK-MSK MAPK signaling pathway","volume":"14","author":"Zhang","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2026.150244_b0725","article-title":"Targeting both the enzymatic and non-enzymatic functions of DHODH as a therapeutic vulnerability in c-Myc-driven cancer","volume":"44","author":"Zhang","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.gene.2026.150244_b0730","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41419-022-05522-0","article-title":"HDAC7\/c-Myc signaling pathway promotes the proliferation and metastasis of choroidal melanoma cells","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150244_b0735","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.ijrobp.2022.11.022","article-title":"Deficiency of carbamoyl phosphate synthetase 1 engenders radioresistance in hepatocellular carcinoma via deubiquitinating c-Myc","volume":"115","author":"Zhang","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.gene.2026.150244_b0740","article-title":"EZH2\/G9a interact to mediate drug resistance in non-small-cell lung cancer by regulating the SMAD4\/ERK\/c-Myc signaling axis","volume":"43","author":"Zhang","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.gene.2026.150244_b0745","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s41419-023-06377-9","article-title":"Upregulation of FAM83F by c-Myc promotes cervical cancer growth and aerobic glycolysis via Wnt\/\u03b2-catenin signaling activation","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150244_b0750","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006230","article-title":"The NR_109\/FUBP1\/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development","volume":"11","author":"Zhang","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.gene.2026.150244_b0755","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41416-025-03119-w","article-title":"The novel role of DUSP4 in suppressing ferroptosis and promoting cytotoxicity of CD8+ T cells in MSI colorectal cancer","volume":"133","author":"Zhang","year":"2025","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.gene.2026.150244_b0760","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41420-022-01001-9","article-title":"HECTD3 promotes gastric cancer progression by mediating the polyubiquitination of c-MYC","volume":"8","author":"Zhang","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.gene.2026.150244_b0765","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41419-021-04174-w","article-title":"Knockdown of OLR1 weakens glycolytic metabolism to repress colon cancer cell proliferation and chemoresistance by downregulating SULT2B1 via c-MYC","volume":"13","author":"Zhao","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150244_b0770","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41392-021-00562-y","article-title":"Long non-coding RNA AFAP1-AS1 accelerates lung cancer cells migration and invasion by interacting with SNIP1 to upregulate c-Myc","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.gene.2026.150244_b0775","article-title":"PRSS23-eIF4E-c-Myc axis promotes gastric tumorigenesis and progression","author":"Zhou","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2026.150244_b0780","first-page":"7","article-title":"The feedback loop of EFTUD2\/c-MYC impedes chemotherapeutic efficacy by enhancing EFTUD2 transcription and stabilizing c-MYC protein in colorectal cancer","volume":"43","author":"Zhu","year":"2024","journal-title":"J. Exp. Clinical Cancer Res. CR"},{"key":"10.1016\/j.gene.2026.150244_b0785","doi-asserted-by":"crossref","first-page":"12628","DOI":"10.1002\/jcb.28529","article-title":"c-Myc mediated upregulation of long noncoding RNA SNHG12 regulates proliferation and drug sensitivity in natural killer\/T-cell lymphoma","volume":"120","author":"Zhu","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.gene.2026.150244_b0790","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1158\/0008-5472.CAN-21-0556","article-title":"Targeting c-Myc to overcome acquired resistance of EGFR mutant NSCLC cells to the third-generation EGFR tyrosine kinase inhibitor, Osimertinib","volume":"81","author":"Zhu","year":"2021","journal-title":"Cancer Res."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926002544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926002544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T12:00:01Z","timestamp":1783166401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111926002544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":158,"alternative-id":["S0378111926002544"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2026.150244","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"c-Myc as a vulnerable target in cancer drug resistance","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2026.150244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"150244"}}